Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease
Arif Yüksel1, Ferda Bilgir2, Oktay Bilgir1
1Department of Internal Medicine, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
Insights
Macrophage migration inhibitory factor (MIF) levels were elevated in acute myocardial infarction patients, suggesting a role in atherosclerosis. E-selectin levels did not differ between patients and controls.
Area of Science:
- Cardiology
- Biochemistry
- Immunology
Background:
- Acute coronary syndrome (ACS) necessitates understanding underlying biomarkers.
- Macrophage migration inhibitory factor (MIF) and E-selectin are implicated in inflammatory and cardiovascular diseases.
Purpose of the Study:
- To investigate plasma levels of MIF and E-selectin in patients with ACS.
- To compare these biomarker levels between patients with acute myocardial infarction (AMI) and non-cardiac chest pain.
Main Methods:
- Plasma MIF and E-selectin were measured in 87 patients presenting with chest pain.
- Patients were categorized into AMI (n=65) and control (non-cardiac chest pain, n=22) groups.
- AMI patients were further subgrouped into ST-elevated myocardial infarction (STEMI, n=30) and non-ST-elevated myocardial infarction (NSTEMI, n=35).
Main Results:
- Plasma MIF levels were significantly higher in both STEMI and NSTEMI subgroups compared to controls.
- Plasma E-selectin levels showed no significant difference between AMI patients and controls.
- No significant difference in MIF levels was observed between STEMI and NSTEMI subgroups.
Conclusions:
- Elevated circulating MIF concentrations are associated with AMI.
- Soluble E-selectin levels do not appear to be significantly altered in AMI.
- MIF may play a role in the pathogenesis of atherosclerosis in ACS.
Background:
To evaluate the macrophage migration inhibitory factor and E-selectin levels in patients with acute coronary syndrome.
Materials/Methods:
We examined the plasma migration inhibitory factor and E-selectin levels in 87 patients who presented with chest pain at our hospital. The patients were classified into two groups according to their cardiac status. Sixty-five patients had acute myocardial infarction, and 22 patients had non-cardiac chest pain (non-coronary disease). We designated the latter group of patients as the control group. The patients who presented with acute myocardial infarction were further divided into two subgroups: ST-elevated myocardial infarction (n = 30) and non-ST elevated myocardial infarction (n = 35).
Results:
We found higher plasma migration inhibitory factor levels in both acute myocardial infarction subgroups than in the control group. However, the E-selectin levels were similar between the acute myocardial infarction and control patients. In addition, we did not find a significant difference in the plasma migration inhibitory factor levels between the ST elevated myocardial infarction and NST-elevated myocardial infarction subgroups.
Discussion:
The circulating concentrations of migration inhibitory factor were significantly increased in acute myocardial infarction patients, whereas the soluble E-selectin levels were similar between acute myocardial infarction patients and control subjects. Our results suggest that migration inhibitory factor may play a role in the atherosclerotic process.
More Related Videos
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Related Concept Videos
Inflammation
Coronary Artery Disease II: Pathophysiology
